Harvard Bioscience Aktie
0,49 €
Deine Einschätzung
Harvard Bioscience Aktie
Was spricht für und gegen Harvard Bioscience in den nächsten Jahren?
Pro
Kontra
Rendite von Harvard Bioscience im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Harvard Bioscience | -0,81 % | 6,52 % | 1,66 % | -57,76 % | -10,91 % | -82,37 % | -86,76 % |
| Simulations Plus | 0,98 % | 1,98 % | -39,41 % | -72,16 % | -33,12 % | -72,16 % | -83,52 % |
| MicroVision Inc | 5,72 % | 14,74 % | -1,05 % | -54,69 % | -2,73 % | -72,29 % | -95,70 % |
| Fonar Corp. New | 0,65 % | 0,65 % | -1,27 % | 9,86 % | 0,00 % | -4,29 % | -1,89 % |
Kommentare
News
Harvard University's Investment Manager Loads Up On 3.87M ETHA Shares
According to a SEC filing dated Feb. 13, 2026, Harvard Management Co. Inc. established a new position in the iShares Ethereum Trust ETF (NASDAQ:ETHA), acquiring 3,870,900 shares. The estimated
Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns
In the last few months of 2025, shares of pharmaceutical giant Eli Lilly and Company (NYSE: LLY) went on an undeniable hot streak. From the beginning of August 2025 to the end of the year, the
Billionaire Ken Griffin Just Bought a Quantum Computing Stock That Could Soar by as Much as 101%, According to Wall Street
When it comes to famous investment personalities, names such as Warren Buffett or Jamie Dimon usually get mentioned first. In the world of hedge funds, though, Ken Griffin is the cream of the crop.




